Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole

Neuroscience

Volumn 133, Issue 4, 2005, Pages 1007-1019

  Ahn, H S ^a   Choi, J S ^a   Choi, B H ^a   Kim, M J ^a   Rhie, D J ^a   Yoon, S H ^a   Jo, Y H ^a   Kim, M S ^a   Sung, K W ^a   Hahn, S J ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

G proteins; Kv1.5; Kv3.1; Riluzole

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); PERTUSSIS TOXIN; POTASSIUM; POTASSIUM CHANNEL; RILUZOLE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; HYPERPOLARIZATION; IC 50; MOLECULAR CLONING; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; STEADY STATE; WHOLE CELL;

ANIMALS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; GUANOSINE DIPHOSPHATE; INHIBITORY CONCENTRATION 50; KINETICS; KV1.5 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PERTUSSIS TOXIN; POTASSIUM CHANNELS, VOLTAGE-GATED; RILUZOLE; SHAW POTASSIUM CHANNELS; THIONUCLEOTIDES;

EID: 20444499385     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.03.041     Document Type: Article

References (40)

1. P. Barnéoud, M. Mazadier, J.M. Miquet, S. Parmentier, P. Dubédat, A. Doble, A. Boireau Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat Neuroscience 74 1996 971 983
2. + channels Br J Pharmacol 140 2003 881 888
3. + channels in myelinated nerve fibre Pflügers Arch 419 1991 603 609
4. G. Bensimon, L. Lacomblez, V. Meininger The ALS/Riluzole Study Group A controlled trial of riluzole in amyotrophic lateral sclerosis N Engl J Med 330 1994 585 591
5. H.M. Bryson, B. Fulton, P. Benfield Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis Drugs 52 1996 549 563
6. Y.J. Cao, J.C. Dreixler, J.J. Couey, K.M. Houamed Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole Eur J Pharmacol 449 2002 47 54
7. B.H. Choi, J.S. Choi, S.H. Yoon, D.J. Rhie, D.S. Min, Y.H. Jo, M.S. Kim, S.J. Hahn Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1 Neuropharmacology 41 2001 443 453
8. B.H. Choi, J.S. Choi, D.J. Rhie, S.H. Yoon, D.S. Min, Y.H. Jo, M.S. Kim, S.J. Hahn Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor Am J Physiol Cell Physiol 282 2002 C1461 C1468
9. M.W. Debono, J. Le Guern, T. Canton, A. Doble, L. Pradier Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes Eur J Pharmacol 235 1993 283 289
10. 3H]aspartate release from cultured cerebellar granule cells Neurosci Lett 140 1992 251 254
11. A. Doble The pharmacology and mechanism of action of riluzole Neurology 47 Suppl 4 1996 233S 241S
12. + channels TREK-1 and TRAAK Mol Pharmacol 57 2000 906 912
13. M. Ettaiche, K. Fillacier, C. Widmann, C. Heurteaux, M. Lazdunski Riluzole improves functional recovery after ischemia in the rat retina Invest Ophthalmol Vis Sci 40 1999 729 736
14. M. Grunnet, T. Jespersen, K. Angelo, C. Frøkjær-Jensen, D.A. Klaerke, S.P. Olesen, B.S. Jensen Pharmacological modulation of SK3 channels Neuropharmacology 40 2001 879 887
15. T. Hebert, P. Drapeau, L. Pradier, R.J. Dunn Block of the rat brain IIA sodium channel αsubunit by the neuroprotective drug riluzole Mol Pharmacol 45 1994 1055 1060
16. C.S. Huang, J.H. Song, K. Nagata, D. Twombly, J.Z. Yeh, T. Narahashi G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons Brain Res 762 1997 235 239
17. C.S. Huang, J.H. Song, K. Nagata, J.Z. Yeh, T. Narahashi Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons J Pharmacol Exp Ther 282 1997 1280 1290
18. J.P. Hubert, J.C. Delumeau, J. Glowinski, J. Prémont, A. Doble Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells evidence for a dual mechanism of action Br J Pharmacol 113 1994 261 267
19. L. Lang-Lazdunski, C. Heurteaux, N. Vaillant, C. Widmann, M. Lazdunski Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping J Thorac Cardiovasc Surg 117 1999 881 889
20. A. Le Liboux, P. Lefebvre, Y. Le Roux, P. Truffinet, M. Aubeneau, S. Kirkesseli, G. Montay Single- and multiple-dose pharmacokinetics of riluzole in white subjects J Clin Pharmacol 37 1997 820 827
21. H.T. Kurata, G.S. Soon, D. Fedida Altered state dependence of C-type inactivation in the long and short forms of human Kv1.5 J Gen Physiol 118 2001 315 332
22. C.M. Macica, L.K. Kaczmarek Casein kinase 2 determines the voltage dependence of the Kv3.1 channel in auditory neurons and transfected cells J Neuroscience 21 2001 1160 1168
23. M.B. Maclver, S.M. Amagasu, A.A. Mikulec, F.A. Monroe Riluzole anesthesia use-dependent block of presynaptic glutamate fibers Anesthesiology 85 1996 626 634
24. J. Mantz, A. Chéramy, A.M. Thierry, J. Glowinski, J.M. Desmonts Anesthetic properties of riluzole (54274 PR), a new inhibitor of glutamate neurotransmission Anesthesiology 76 1992 844 848
25. D. Martin, M.A. Thompson, J.V. Nadler The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1 Eur J Pharmacol 250 1993 473 476
26. V. Mary, F. Wahl, J.M. Stutzmann Effect of riluzole on quinolinate-induced neuronal damage in rats; comparison with blockers of glutamatergic neurotransmission Neurosci Lett 201 1995 92 96
27. + channels by riluzole comparison with established anticonvulsants and class I anti-arrhythmics Fundam Clin Pharmacol 14 2000 107 117
28. A and glycine receptor channels Eur J Pharmacol 415 2001 135 140
29. T. Narahashi Neuroreceptors and ion channels as the basis for drug action past, present, and future J Pharmacol Exp Ther 294 2000 1 26
30. T.M. Perney, J. Marshall, K.A. Martin, S. Hockfield, L.K. Kaczmarek Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain J Neurophysiol 68 1992 756 766
31. J. Pratt, J. Rataud, F. Bardot, M. Roux, J.C. Blanchard, P.M. Laduron, J.M. Stuzmann Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia Neurosci Lett 140 1992 225 230
32. A. Siniscalchi, C. Zona, G. Sancesario, E. D'Angelo, Y.C. Zeng, N.B. Mercuri, G. Bernardi Neuroprotective effects of riluzole an electrophysiological and histological analysis in an in vitro model of ischemia Synapse 32 1999 147 152
33. J.H. Song, C.S. Huang, K. Nagata, J.Z. Yeh, T. Narahashi Differential Action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels J Pharmacol Exp Ther 282 1997 707 714
34. + channel cDNAs from human ventricle FASEB J 5 1991 331 337
35. + channels as targets for neuroprotective drugs Trends Pharmacol Sci 16 1995 309 316
36. T. Tsuneizumi, S.M. Babb, B.M. Cohen Drug distribution between blood and brain as a determinant of antipsychotic drug effects Biol Psychiatry 32 1992 817 824
37. F. Wahl, J.M. Stutzmann Neuroprotective effects of riluzole in neurotrauma models a review Acta Neurochir Suppl 73 1999 103 110
38. 3 cells J Invest Med 47 1999 484 495
39. L. Xu, J.A. Enyeart, J.J. Enyeart Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism J Pharmacol Exp Ther 299 2001 227 237
40. C. Zona, A. Siniscalchi, N.B. Mercuri, G. Bernardi Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons Neuroscience 85 1998 931 938